Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Shares Outstanding (2016 - 2025)

Lisata Therapeutics' Shares Outstanding history spans 13 years, with the latest figure at $8.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 5.06% year-over-year to $8.8 million; the TTM value through Dec 2025 reached $8.8 million, up 5.06%, while the annual FY2025 figure was $8.8 million, 5.06% up from the prior year.
  • Shares Outstanding reached $8.8 million in Q4 2025 per LSTA's latest filing, up from $8.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $8.8 million in Q4 2025 to a low of $8.0 million in Q1 2023.
  • Average Shares Outstanding over 3 years is $8.4 million, with a median of $8.3 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding: rose 2.21% in 2024, then grew 5.24% in 2025.
  • A 3-year view of Shares Outstanding shows it stood at $8.2 million in 2023, then increased by 3.16% to $8.4 million in 2024, then grew by 5.06% to $8.8 million in 2025.
  • Per Business Quant, the three most recent readings for LSTA's Shares Outstanding are $8.8 million (Q4 2025), $8.8 million (Q3 2025), and $8.6 million (Q2 2025).